Login to Your Account



Genentech's Heart Attack Drug, Anti-CD18, Fails In Phase II Trial


Monday, June 19, 2000
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription